Related Experiment Video
Updated: Aug 22, 2025

Author Spotlight: Insight Into Advances in Prion Diseases Research
Published on: August 11, 2023
Apoptotic MSCs and MSC-Derived Apoptotic Bodies as New Therapeutic Tools
Irina V Kholodenko1, Roman V Kholodenko2, Alexander G Majouga3
1Laboratory of Cell Biology, Orekhovich Institute of Biomedical Chemistry, 119121 Moscow, Russia.
Abstract:
Over the past two decades, mesenchymal stem cells (MSCs) have shown promising therapeutic effects both in preclinical studies (in animal models of a wide range of diseases) and in clinical trials. However, the efficacy of MSC-based therapy is not always predictable. Moreover, despite the large number of studies, the mechanisms underlying the regenerative potential of MSCs are not fully elucidated. Recently, it has been reliably established that transplanted MSCs can undergo rapid apoptosis and clearance from the recipient's body, still exhibiting therapeutic effects, especially those associated with their immunosuppressive/immunomodulating properties. The mechanisms underlying these effects can be mediated by the efferocytosis of apoptotic MSCs by host phagocytic cells. In this concise review, we briefly describe three types of MSC-generated extracellular vesicles, through which their therapeutic functions can potentially be carried out; we focused on reviewing recent data on apoptotic MSCs and MSC-derived apoptotic bodies (MSC-ApoBDs), their functions, and the mechanisms of their therapeutic effects.
Insights
Mesenchymal stem cells (MSCs) show therapeutic promise, but mechanisms remain unclear. Apoptotic MSCs and their derived bodies mediate effects via efferocytosis, offering insights into MSC therapy.
Area of Science:
- Regenerative Medicine
- Immunology
- Cell Biology
Background:
- Mesenchymal stem cells (MSCs) demonstrate therapeutic potential in preclinical and clinical studies.
- The precise mechanisms driving MSC therapeutic efficacy and regenerative potential are not fully understood.
- Transplanted MSCs can undergo apoptosis and clearance while retaining therapeutic effects, particularly immunomodulation.
Purpose of the Study:
- To review recent data on apoptotic MSCs and MSC-derived apoptotic bodies (MSC-ApoBDs).
- To explore the functions and therapeutic mechanisms of apoptotic MSCs and MSC-ApoBDs.
- To discuss MSC-generated extracellular vesicles involved in therapeutic functions.
Main Methods:
- Concise review of existing literature.
- Focus on recent findings regarding apoptotic MSCs and MSC-ApoBDs.
- Analysis of efferocytosis as a mechanism for MSC therapeutic effects.
Main Results:
- Apoptotic MSCs and MSC-ApoBDs can mediate therapeutic effects, especially immunomodulatory ones.
- Efferocytosis of apoptotic MSCs by host phagocytic cells is a key mechanism.
- MSC-derived extracellular vesicles, including apoptotic bodies, are crucial for therapeutic functions.
Conclusions:
- Apoptotic MSCs and their derived extracellular vesicles, particularly MSC-ApoBDs, play a significant role in MSC-based therapy.
- Understanding efferocytosis and vesicle-mediated mechanisms is vital for optimizing MSC therapeutic strategies.
- Further research into these mechanisms can enhance the predictability and efficacy of MSC treatments.
Related Concept Videos
Mesenchymal Stem Cells
The Extrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...

